Real experience of prophylaxis with emicizumab in patients with congenital haemophilia A with and without FVIII inhibitors in the HCUVA

被引：0
|
作者：
Heredia Cano, Angela [1 ]
Garcia Candel, Faustino [1 ]
Sanchez Villalobos, Maria [1 ]
Poveda Garcia, Andrea [1 ]
Torchia Esteban, Marcos [1 ]
Ruiz Ruiz, Estela [1 ]
Sanchez Salas, Jose Antonio [1 ]
Navarro Almenzar, Begona [1 ]
Caracena Lopez, Sara [2 ]
Perez Laencina, Marta [1 ]
Blazquez Soto, Juan Antonio [1 ]
机构：
[1] Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain
[2] Hosp Gen Univ Morales Meseguer, Murcia, Spain
来源：
HAEMOPHILIA | 2024年 / 30卷
关键词：
congenital haemophilia A; emicizumab; real experience;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-022 (1
引用
收藏
页码：31 / 32
页数：2
相关论文
共 50 条
  • [1] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    [J]. HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [2] Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    [J]. HAEMOPHILIA, 2020, 26 (01) : 41 - 46
  • [3] EMICIZUMAB PROPHYLAXIS IN ADULT AND PAEDIATRIC HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS: A SINGLE CENTRE REAL WORLD EXPERIENCE
    Catalano, A.
    Di Gregorio, P.
    Di Cocco, M. L.
    Malizia, R.
    Paolini, F.
    Verna, S.
    [J]. HAEMOPHILIA, 2021, 27 : 70 - 70
  • [4] HAVEN 2: Emicizumab Prophylaxis for Children with Haemophilia A with FVIII Inhibitors
    Young, G.
    Liesner, R.
    Sidonio, R.
    Oldenburg, J.
    Jimenez-Yuste, V.
    Malangu, J.
    Kruse-Jarres, R.
    Wang, M.
    Chang, T.
    Uguen, M.
    Doral, M.
    Schmitt, C.
    Levy, G.
    Shima, M.
    Mancuso, M. E.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 30 - 31
  • [5] Real-world experience with the use of emicizumab in paediatric haemophilia A patients with and without inhibitors
    Lam, Joyce Ching Mei
    Lim, Chiew Ying
    Kadir, Nur Insyirah Abdul
    [J]. HAEMOPHILIA, 2022, 28 : 50 - 51
  • [6] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    [J]. HAEMOPHILIA, 2021, 27 : 70 - 70
  • [7] Long-term analysis of real clinical practice of emicizumab treatment in patients with severe haemophilia A with and without FVIII inhibitors
    Zozulya, N.
    Dimitrieva, O.
    Yakovleva, E.
    [J]. HAEMOPHILIA, 2024, 30 : 122 - 122
  • [8] PROPHYLAXIS WITH EMICIZUMAB IN HAEMOPHILIA A PATIENTS WITH INHIBITORS: DATA OF A PORTUGUESE CONGENITAL COAGULOPATHIES REFERENCE CENTRE
    Sousa, M.
    Vaz, C.
    Fernandes, S.
    Oliveira, M.
    Carvalho, M.
    Lopes, M.
    Koch, C.
    [J]. HAEMOPHILIA, 2021, 27 : 110 - 110
  • [9] RESOURCE CONSUMPTION ANALYSIS IN PATIENTS WITH HEMOPHILIA A WITHOUT INHIBITORS ON PROPHYLAXIS WITH FVIII BEFORE SWITCHING TO EMICIZUMAB
    Giacomini, E.
    Leogrande, M.
    Motta, L.
    Tempre, R.
    Bendinelli, S.
    Degli Esposti, L.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S69 - S69
  • [10] REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Wall, C.
    Xiang, H.
    Palmer, B.
    Collins, P. W.
    Stephensen, D.
    Scott, M.
    Chalmers, E.
    Chowdary, P.
    Hall, G. W.
    Liesner, R.
    Hart, D. P.
    Shapiro, S.
    Talks, K.
    Fletcher, S.
    Hay, C. R.
    [J]. HAEMOPHILIA, 2021, 27 : 116 - 116
12345